References:
1. Teh BL, Khan MK, Butt A, Kuffova L. Bilateral ocular involvement with
syphilis in a known HIV patient. Am J Ophthalmol Case Rep .
2020;18:100638. doi:10.1016/j.ajoc.2020.100638
2. Albini T, Callaway NF, Pershing S, Wang SK, Moshfeghi AA, Moshfeghi
DM. Trends in Hospitalization and Incidence Rate for Syphilitic Uveitis
in the United States From 1998 to 2009. Am J Ophthalmol .
2017;180:133-141. doi:10.1016/j.ajo.2017.05.013
3. Schulz DC, Orr SMA, Johnstone R, Devlin MK, Sheidow TG, Bursztyn
LLCD. The many faces of ocular syphilis: case-based update on
recognition, diagnosis, and treatment. Can J Ophthalmol .
Published online February 2021:S0008418221000168.
doi:10.1016/j.jcjo.2021.01.006
4. Kiss S, Damico FM, Young LH. Ocular Manifestations and Treatment of
Syphilis. Semin Ophthalmol . 2005;20(3):161-167.
doi:10.1080/08820530500232092
5. Eslami M. Resurgence of ocular syphilis in British Columbia between
2013–2016: a retrospective chart review. 2020;55(2):6.
6. Anthony J. Aldave, MD,* Julie A. King, MD,† and Emmett T. Cunningham,
Jr., MD, PhD, MPH*. Ocular syphilis. Curr Opin Ophthalmol .
2001;12(6):433-441. doi:10.1097/00055735-200112000-00008
7. Moradi A, Salek S, Daniel E, et al. Clinical Features and Incidence
Rates of Ocular Complications in Patients With Ocular Syphilis. Am
J Ophthalmol . 2015;159(2):334-343.e1. doi:10.1016/j.ajo.2014.10.030
8. Furtado JM, Arantes TE, Nascimento H, et al. Clinical Manifestations
and Ophthalmic Outcomes of Ocular Syphilis at a Time of Re-Emergence of
the Systemic Infection. Sci Rep . 2018;8(1):12071.
doi:10.1038/s41598-018-30559-7
9. Tsuboi M, Nishijima T, Yashiro S, et al. Time to development of
ocular syphilis after syphilis infection. J Infect Chemother .
2018;24(1):75-77. doi:10.1016/j.jiac.2017.08.006